SCHEMBL125148

SCHEMBL125148

O=S(=O)([O-])c1ccc2ccccc2c1.[Na+]

nearest known ligand 0.63

Known targets — ChEMBL curated mechanism

OPRM1

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.63
L3MBTL1 Q9Y468 1/20 0.57
F2 P00734 2/20 0.52
PRSS1 P07477 2/20 0.52
PRSS2 P07478 2/20 0.52
PRSS3 P35030 2/20 0.52
MCOLN3 Q8TDD5 3/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
TSHR P16473 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
DUSP5 Q16690 1/20 0.47
ATM Q13315 1/20 0.47
CYP19A1 P11511 1/20 0.47
PKM P14618 1/20 0.47
GPR84 Q9NQS5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12234418 1.00 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
SCHEMBL29368068 1.00 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
SCHEMBL30079649 1.00 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
SCHEMBL30033020 1.00 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
Formaldehyde SCHEMBL912817 0.96 LMNA (0.59) LMNAL3MBTL1F2PRSS1PRSS2
SCHEMBL2238091 0.95 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
SCHEMBL587370 0.95 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
SCHEMBL9888371 0.95 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
Silver SCHEMBL1177403 0.95 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2
Lithium Ion SCHEMBL1457859 0.95 LMNA (0.63) LMNAL3MBTL1F2PRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1053 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12564546-B2 Self-tanning compositions containing an aromatic sulfonate and methods thereof KAO CORPORATION (JP) 2026-03-03 US claimed
CN-119843345-A Electrolytic etching solution, electrolytic etching method, metal-plastic composite material and electronic equipment 比亚迪股份有限公司 2025-04-18 CN claimed
CN-115210324-B Coloring composition and color filter DIC株式会社 2025-02-21 CN claimed
CN-119490739-A TPU wire rod and preparation method thereof 深圳市德同兴电子股份有限公司 2025-02-21 CN claimed
WO-2025006106-A1 QUANTIFYING ZONAL FLOW IN MULTI-LATERAL WELLS VIA TAGGANTS OF FLUIDS SAUDI ARABIAN OIL COMPANY (SA) 2025-01-02 WO claimed
US-20250003331-A1 Quantifying Zonal Flow in Multi-lateral Wells via Taggants of Fluids SAUDI ARABIAN OIL COMPANY (SA) 2025-01-02 US claimed
CN-118870853-A Chemical molecule modified perovskite passivation structure, solar cell, light-emitting diode and photoelectric detector preparation method 中国科学技术大学 2024-10-29 CN claimed
CN-118437167-A Fluorine-containing polyamide organic solvent nanofiltration membrane and preparation method thereof 北京工业大学 2024-08-06 CN claimed
US-12053461-B2 Amlodipine formulations AZURITY PHARMACEUTICALS, INC. (US) 2024-08-06 US claimed
US-20240225974-A9 HAIR COSMETIC KAO CORPORATION (JP) 2024-07-11 US claimed
EP-0473698-A1 METHOD OF PREPARING D-PROPOXYPHENE. MALLINCKRODT INC (US) 1992-03-11 EP claimed
EP-0400657-A2 Process for developing of ps plates requiring no dampening water Fuji Photo Film Co., Ltd. (JP) 1990-12-05 EP claimed
WO-1990014331-A1 METHOD OF PREPARING D-PROPOXYPHENE MALLINCKRODT, INC. (US) 1990-11-29 WO claimed
US-4633024-A Process for producing aromatic hydroxy compound KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) 1986-12-30 US claimed
EP-0004740-B1 A PENICILLIN SALT, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT BEECHAM GROUP PLC (GB) 1982-01-20 EP claimed
US-4287297-A WHEREIN THE COMPOSITION CONTAINS A SODIUM SALT OF AN AROMATIC ACID OR SULFONIC ACID DAICEL CHEMICAL INDUSTRIES LTD. (JP) 1981-09-01 US claimed
US-4263201-A ORGANIC ACID METAL SALT, HALOGEN COMPOUND GENERAL ELECTRIC COMPANY (US) 1981-04-21 US claimed
US-4225311-A Dye composition containing a copolymer of ethylene oxide and propylene oxide as nonionic surfactant KAO SOAP CO., LTD. (JP) 1980-09-30 US claimed
EP-0004740-A2 A penicillin salt, process for its preparation and pharmaceutical compositions containing it BEECHAM GROUP PLC (GB) 1979-10-17 EP claimed
US-3957674-A SODIUM NAPHTHALENESULFONATE SURFACTANT SHIN NIHON KAGAKU KOGYO KABUSHIKI KAISHA (JA) 1976-05-18 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12053461-B2 Amlodipine formulations CACNA1D, CAD, CACNA1C LMNA 260/4885L3MBTL1 4205/4885F2 3173/4885
US-12564546-B2 Self-tanning compositions containing an aromatic sulfonate and methods thereof CUTA, TYR, TREH LMNA 645/4885L3MBTL1 4217/4885F2 2559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.